Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SOCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BCL2L13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGPAT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCGF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAFF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP42 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAPSS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APOL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100129518 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HSH2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAFD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPATCH2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APCDD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERPINB8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on